Latest News in the pharma Industry

Biopharma News

Dual inhibitor targets neurodegenerative disease

Dual inhibitor targets neurodegenerative disease

5 Aug 2013

The drug may target LRRK2 and JNK enzymes in order to reduce Parkinson's symptoms and slow disease progression.

Read more 
Pharmaceutical submits NDA for new hypertension treatment

Pharmaceutical submits NDA for new hypertension treatment

1 Aug 2013

An NDA has been submitted for a new treatment targeting hypertension

Read more 
64% of children readmitted to hospital after stem cell treatment

64% of children readmitted to hospital after stem cell treatment

1 Aug 2013

Research has revealed 64 per cent of children have been readmitted to hospital after stem cell transplants.

Read more 
Routine Generation of Powder Samples from HPLC Fractions

Routine Generation of Powder Samples from HPLC Fractions

12 Jul 2013

Read more 
CATALENT CREATES NEW ADVANCED DELIVERY TECHNOLOGIES BUSINESS UNIT

CATALENT CREATES NEW ADVANCED DELIVERY TECHNOLOGIES BUSINESS UNIT

9 Jul 2013

Read more 
CATALENT CREATES NEW ADVANCED DELIVERY TECHNOLOGIES BUSINESS UNIT

CATALENT CREATES NEW ADVANCED DELIVERY TECHNOLOGIES BUSINESS UNIT

9 Jul 2013

Read more 
African plants may prevent the growth of tumours

African plants may prevent the growth of tumours

11 Jun 2013

Researchers have reported that benzophenone, which is found in African plants, could prevent tumours from growing.

Read more 
New treatment for type 1 diabetes being piloted in clinical trial

New treatment for type 1 diabetes being piloted in clinical trial

11 Jun 2013

Researchers are looking at a new treatment for reducing the amount of times a person needs to take insulin for type 1 diabtes.

Read more 
Dermira secures raises funding for dermatology innovation

Dermira secures raises funding for dermatology innovation

11 Jun 2013

The company is aiming develop and commercialise innovative new therapies in dermatology.

Read more 
BioFocus signs agreement with Aviva Investors for construction of new laboratory and HQ building at Chesterford Research Park

BioFocus signs agreement with Aviva Investors for construction of new laboratory and HQ building at Chesterford Research Park

9 Jun 2013

Read more 
Vela Laboratories and Evercyte Announce Cooperation to Provide Immortalized Cell Lines for Biosimilar Characterization

Vela Laboratories and Evercyte Announce Cooperation to Provide Immortalized Cell Lines for Biosimilar Characterization

9 Jun 2013

Read more 
Draft Guideline ICH Q3D for Elemental Impurities Published

Draft Guideline ICH Q3D for Elemental Impurities Published

8 Jun 2013

Read more